Daré Bioscience, Inc.
DARE
$0.72
$0.011.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.99M | -12.02M | -13.40M | -17.46M | -18.60M |
| Total Depreciation and Amortization | 2.14M | 2.03M | 1.65M | 1.12M | 645.90K |
| Total Amortization of Deferred Charges | -11.60K | -11.60K | -11.60K | 102.40K | -21.90K |
| Total Other Non-Cash Items | 2.28M | 2.20M | 2.09M | 2.44M | 2.53M |
| Change in Net Operating Assets | -4.71M | -2.13M | -210.70K | 7.78M | 3.94M |
| Cash from Operations | -11.29M | -9.94M | -9.89M | -6.02M | -11.51M |
| Capital Expenditure | -461.90K | -227.90K | -385.20K | -741.40K | -284.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -461.90K | -227.90K | -385.20K | -741.40K | -284.40K |
| Total Debt Issued | 486.70K | 486.70K | 486.70K | 486.70K | 561.70K |
| Total Debt Repaid | -2.64M | -2.71M | -1.82M | -1.48M | -1.02M |
| Issuance of Common Stock | 20.28M | 20.59M | 20.93M | 19.71M | 966.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.53M | 297.20K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -350.20K | -347.70K | -321.70K | -79.60K | -80.00K |
| Cash from Financing | 19.31M | 18.32M | 19.28M | 18.64M | 427.90K |
| Foreign Exchange rate Adjustments | 27.90K | 38.60K | 7.20K | -33.30K | -17.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.58M | 8.19M | 9.01M | 11.84M | -11.38M |